Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication

NCT01268553 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Treprostinil

Sponsor

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Collaborators

[object Object]